News
FirstLight and RadiantLight evaluated the safety and efficacy of oveporexton for the treatment of narcolepsy with cataplexy in participants aged 16 to 70 years old.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback